Form 4: Performant Financial Corp CEO Simeon Kohl Receives Restricted Stock Units

CEO of Performant Financial Corp, Simeon Kohl, was granted restricted stock units on August 5, 2024, subject to service and performance-based vesting conditions.

Summary

• Simeon Kohl, the CEO of Performant Financial Corp, received two grants of restricted stock units (RSUs) on August 5, 2024.
• The first grant consists of 157,895 RSUs that vest in four equal installments on the anniversaries of the grant date, contingent upon continuous service, and fully upon a change in control.
• The second grant consists of 157,894 RSUs divided into three tranches, vesting upon achievement of target healthcare revenue amounts.
• Tranche 1 (52,105 RSUs) vests upon achieving a $135M trailing twelve-month healthcare revenue target within three years.
• Tranche 2 (52,105 RSUs) vests upon achieving a $155M trailing twelve-month healthcare revenue target within three years.
• Tranche 3 (53,684 RSUs) vests upon achieving a $175M trailing twelve-month healthcare revenue target within four years.
• Failure to meet the target revenue amounts within the specified timeframes results in forfeiture of the respective RSU tranches.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice, and the performance-based vesting aligns management's interests with shareholders. However, the risk of forfeiture if targets are not met tempers the positivity.

Positives

• The vesting schedule of the RSUs is tied to both continued service and the achievement of specific revenue targets, aligning management's interests with those of the shareholders.
• The performance-based vesting provides an incentive for the CEO to drive revenue growth.

Negatives

• Failure to achieve the revenue targets will result in the forfeiture of the corresponding RSU tranches, which could be seen as a negative if the targets are perceived as overly ambitious.

Risks

• The company may not achieve the target revenue amounts required for the performance-based RSUs to vest.
• Changes in the healthcare industry or the company's competitive landscape could impact its ability to achieve the revenue targets.

Future Outlook

The vesting of the performance-based RSUs is contingent upon the company achieving specific healthcare revenue targets over the next three to four years.

Industry Context

Equity compensation is a common practice in the financial and healthcare industries to incentivize executives and align their interests with those of shareholders. The use of performance-based vesting is also a common practice to ensure that executives are rewarded for achieving specific financial goals.

Comparison to Industry Standards

• Comparing Performant Financial Corp's executive compensation structure to similar companies in the financial and healthcare sectors reveals a common trend of utilizing restricted stock units with vesting schedules tied to both time and performance metrics.
• For example, companies like Encompass Health and UnitedHealth Group also employ RSUs as part of their executive compensation packages, often linking vesting to revenue growth, profitability, or other key performance indicators.
• The specific revenue targets set for Performant's CEO, such as $135M, $155M, and $175M, would need to be benchmarked against the company's historical performance and industry growth rates to determine their relative difficulty and appropriateness.
• Additionally, the vesting timelines of 3-4 years are fairly standard in the industry, aligning with the typical strategic planning horizons of most companies.

Stakeholder Impact

• Shareholders: The vesting of RSUs based on revenue targets could positively impact shareholder value if the targets are achieved.
• Employees: The achievement of revenue targets could lead to increased job security and potential bonuses.
• Customers: The focus on revenue growth could lead to improved services and customer satisfaction.

Key Dates